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Abstract 
Due to the complexity and the heterogeneity of biological systems, mathematical models 
that take into account cell signalling, cell population behaviour and the extracellular 
environment are particularly helpful. A methodology to instantiate any generic logical 
model to a set of cancer patients has been developed to capture their diversity of 
functioning and response to perturbations. This framework allows for simulations tailored 
to a cell line or a patient’s sample using a Boolean model of cancer. The method permits 
to compare these simulations to clinical data, such as drug response and survival time, 
but also to additional data analyses such as Independent Component Analysis. 
Another open-source software that has also been developed in our group, PhysiBoSS, 
combines intracellular signalling using Boolean modelling (MaBoSS) and multicellular 
behaviour using agent-based modelling (PhysiCell). PhysiBoSS provides a flexible and 
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computationally efficient framework to explore the effect of environmental and genetic 
alterations of individual cells at the population level, bridging the critical gap from 
genotype to phenotype.  
The combination of those two tools pave the way to provide better insights into patient-
specific response to treatments, mutation effects and different modes of invasion among 
other. 
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